Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry A Jacobson

Showing results (111-120 of 182) with videos related to

Pageof 19
Sort By:
Journal of Clinical Lipidology|September 6, 2022
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid AssociationDon P Wilson, Terry A Jacobson, Peter H Jones, et al.
Journal of Clinical Lipidology|May 24, 2017
Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid AssociationCarl E Orringer, Terry A Jacobson, Joseph J Saseen, et al.
Patient Education and Counseling|March 9, 2007
Development of an illustrated medication schedule as a low-literacy patient education toolSunil Kripalani, Rashanda Robertson, Melissa H Love-Ghaffari, et al.
Journal of Clinical Lipidology|June 9, 2020
Genetic testing in dyslipidemia: A scientific statement from the National Lipid AssociationEmily E Brown, Amy C Sturm, Marina Cuchel, et al.
Clinical Cardiology|October 21, 2010
Combination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studiesCarl J Pepine, Terry A Jacobson, Dawn M Carlson, et al.
Journal of Clinical Lipidology|May 6, 2014
An assessment by the Statin Muscle Safety Task Force: 2014 updateRobert S Rosenson, Steven K Baker, Terry A Jacobson, et al.
Archives of Internal Medicine|March 8, 2003
Risk for myopathy with statin therapy in high-risk patientsChristie M Ballantyne, Alberto Corsini, Michael H Davidson, et al.
Journal of Clinical Lipidology|February 19, 2013
Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical settingMark J Cziraky, Vincent J Willey, James M McKenney, et al.
Obesity Pillars|May 6, 2024
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024Harold Edward Bays, Carol Kirkpatrick, Kevin C Maki, et al.
The American Journal of Cardiology|April 26, 2003
Management of persons with high risk of coronary heart disease but low serum low-density lipoprotein cholesterolChristopher C Case, Terry A Jacobson, Susan Roberts, et al.
Pageof 19

Showing results (111-120 of 182) with videos related to

Sort By:
Pageof 19
Journal of Clinical Lipidology|September 6, 2022
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid AssociationDon P Wilson, Terry A Jacobson, Peter H Jones, et al.
Journal of Clinical Lipidology|May 24, 2017
Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid AssociationCarl E Orringer, Terry A Jacobson, Joseph J Saseen, et al.
Patient Education and Counseling|March 9, 2007
Development of an illustrated medication schedule as a low-literacy patient education toolSunil Kripalani, Rashanda Robertson, Melissa H Love-Ghaffari, et al.
Journal of Clinical Lipidology|June 9, 2020
Genetic testing in dyslipidemia: A scientific statement from the National Lipid AssociationEmily E Brown, Amy C Sturm, Marina Cuchel, et al.
Clinical Cardiology|October 21, 2010
Combination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studiesCarl J Pepine, Terry A Jacobson, Dawn M Carlson, et al.
Journal of Clinical Lipidology|May 6, 2014
An assessment by the Statin Muscle Safety Task Force: 2014 updateRobert S Rosenson, Steven K Baker, Terry A Jacobson, et al.
Archives of Internal Medicine|March 8, 2003
Risk for myopathy with statin therapy in high-risk patientsChristie M Ballantyne, Alberto Corsini, Michael H Davidson, et al.
Journal of Clinical Lipidology|February 19, 2013
Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical settingMark J Cziraky, Vincent J Willey, James M McKenney, et al.
Obesity Pillars|May 6, 2024
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024Harold Edward Bays, Carol Kirkpatrick, Kevin C Maki, et al.
The American Journal of Cardiology|April 26, 2003
Management of persons with high risk of coronary heart disease but low serum low-density lipoprotein cholesterolChristopher C Case, Terry A Jacobson, Susan Roberts, et al.
Pageof 19